Abstract Library

#2987 68Ga-DOTATOC PET/CT as Tool for Diagnosis and Decision-Making Process of Neuroendocrine Tumors

Introduction: Primary tumors in some patients with metastatic neuroendocrine tumors (NET) cannot be found by conventional imaging as CT, MRI and scintigraphy. 68Ga-DOTATOC PET/CT (68Ga-PET) appears to have superior sensitivity, specifity, and better resolution than 99mTC-octreotide SPECT/TC (SSTR scintigraphy) and can improve decision-making process, however its cost is higher, and its availability is limited.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Peiró I, Vercher-Conejero J, Suils-Ramón J, Hernández L, Teulé A,

Keywords: 68Ga-DOTATOC PET/CT, metastatic neuroendocrine tumors,

#2277 Neuroendocrine Tumors Committee of Reference Hospital: Decision-Making Process on the Diagnostic and Therapeutic Approach to Patients with Neuroendocrine Tumors

Introduction: Neuroendocrine tumors (NETs) require a multidisciplinary approach in expert centers due to their rarity, heterogeneity and the lack of evidence about optimal clinical management.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Jimenez-Fonseca P, Valdes N, Fernandez del Valle A, Miguel C, Lauret M,

Keywords: committee, decision-making process, multidisciplinary, tool, treatment,

#1682 Clinicohistopathological Features and Treatment Outcomes of Neuroendocrine Tumors; A Single Center Experience

Introduction: Neuroendocrine tumors (NETs) are very heterogeneous family of cancers.Tumor and patient characteristics of NETs significantly change between geographical locations that probably induced by environmental and genetic factors throughout the world. Therefore, reporting single center experience may help to clarify epidemiological view and to improve the decision-making process.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Sumbul A

Authors: Sumbul A, Sedef A, Kose F, Mertsoylu H, Sezer A,

Keywords: Neuroendocrine tumors, single center,